Therefore, the current study goal was to elucidate the potential anti-fibrotic effects of diacerein on BDL-induced liver fibrosis and the probable related mechanism, with emphasis on HMGB1/RAGE pathway. The gene discussed is AGER; the disease is Hepatic fibrosis.